Home » Newsletters » BioWorld Science

BioWorld Science

July 10, 2014

View Archived Issues

Chinese team divulges novel BTK inhibitors

AstraZeneca and Max Planck Institute to create CVMD chemistry unit

Cynapsus Therapeutics receives grant and plans phase II study of sublingual apomorphine

Otonomy releases phase III data for AuriPro in middle ear effusion

Peroxynitrite decomposing catalyst has antidiabetic effects

Researchers present results for BP-C1 in patients with stage IV breast cancer

Phase III results for trelagliptin, an oral, once-weekly DPP IV inhibitor

LAPS-CA-Exendin 4 designed for patients with type 2 diabetes

Novel SYK inhibitors described by Merck & Co.

Actelion Pharmaceuticals prepares new P2X7 antagonists

Researchers at Pfizer disclose novel BACE inhibitors

New MAbs for influenza A virus patented by Belgian researchers

U.S. researchers design new series of protein kinase inhibitors for cancer

Researchers present phase I results for LGD-6972

A1M Pharma pre-eclampsia therapy receives European orphan drug designation

Celgene reports data from phase III POSTURE study

La Jolla Pharmaceutical to conduct phase III registration program for LJPC-501

Salix Pharmaceuticals to merge with Cosmo Technologies

Akashi Therapeutics presents data on HT-100 in Duchenne muscular dystrophy

Sunesis Pharmaceuticals receives positive opinion on pediatric investigation plan for vosaroxin

Vaccine for ricin and anthrax achieves simultaneous protection milestone

Valeant Pharmaceuticals acquires PreCision Dermatology

FDA places clinical hold on Revolixys Kit phase III trial

Nuvilex completes preparations for preclinical studies of encapsulated cells in ascites

Astellas files NDA for isavuconazole in invasive fungal infections

AbbVie makes revised conditional non-binding proposal offer to Shire

Humanetics awarded NCI grant to test BIO-300 for radiation-induced erectile dysfunction

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...